m-PEG-NHS Ester plays a key role in pharmaceutical research. It reacts with amine-containing molecules like proteins and peptides, enhancing drug solubility and bioavailability. Its hydrophilic and biocompatible properties boost the stability of drug delivery systems and reduce immune responses. Researchers rely on it for site-specific protein labeling, enabling targeted therapies that deliver drugs directly to specific tissues while minimizing side effects.
M-PEG-NHS ester
m-PEG-NHS Ester is a versatile PEG derivative widely used in pharmaceutical research. It features an N-hydroxysuccinimide (NHS) ester group that actively reacts with amine-containing molecules like proteins, peptides, and drugs. This reaction improves drug solubility, bioavailability, and pharmacokinetics. Due to its hydrophilic and biocompatible nature, m-PEG-NHS Ester is ideal for modifying drug delivery systems, enhancing stability, and reducing immunogenicity.
Additionally, researchers use m-PEG-NHS Ester for site-specific labeling of proteins and peptides, making it easier to track biological processes. It plays a critical role in targeted therapies, as it allows drugs to reach specific cells or tissues while minimizing toxicity.
Key Features:
- NHS Ester Reactivity: Efficiently binds to primary amines in proteins and peptides.
- Biocompatibility: Offers safe and reliable use in pharmaceutical applications.
- Hydrophilic: Enhances both solubility and stability in drug formulations.
Applications:
- Drug Delivery: Boosts stability and reduces immune response in drug systems.
- Protein Labeling: Allows precise tracking and analysis of biological processes.
- Targeted Therapies: Delivers drugs directly to specific tissues, lowering side effects.
Storage:
Store in a cool, dry place, and protect it from light to maintain its reactivity and effectiveness.